Business Standard

Narayana Health develops liquid biopsy as alternative to surgical process

Currently this product has been launched for detection of cancers of the liver and colon. For leukemia, or blood cancer, further research is being conducted

(From left to right) Ashutosh Raghuvanshi, MD, Narayana Hrudayaya and Devi Shetty, Chairman, Narayana Hrudayaya at a press conference announcing the company's IPO plans in Mumbai (pic: Suryakant Niwate)
Premium

(From left to right) Ashutosh Raghuvanshi, MD, Narayana Hrudayaya and Devi Shetty, Chairman, Narayana Hrudayaya at a press conference announcing the company's IPO plans in Mumbai (pic: Suryakant Niwate)

Gina Krishnan New Delhi
A burgeoning population and the advent of a range of new pathogenic and lifestyle diseases has made healthcare in India extremely complex. The medical fraternity has risen to the occasion at every step to meet the challenges in maintaining and improving public health, delivering several new molecules and therapeutic procedures to improve the overall well being of the populace. In a new series, Business Standard brings you five institutions that stand out in the field of medical research in India. 
------------------------

One of the fastest growing hospital chains from the south, Narayana Health set up its first institution in  Bengaluru. 

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in